Andrew Chapman

Andrew Chapman is a Senior Director at AstraZeneca, specializing in transformation, strategy, and operations with a focus on digital and AI innovation. With over 22 years of experience, they previously held positions as Executive Director at 42 Technology Ltd, where they led technology consulting and innovation ventures, and as Vice President at Sagentia Innovation, addressing complex challenges in medical R&D. Additionally, Andrew has contributed to digital health initiatives as the Sector Lead at Digital Catapult and as a business mentor at the University of Cambridge. They earned a degree in Mechanical Engineering from Loughborough University, an MBA from The Open University, and completed a program in Machine Learning at Stanford University.